242 related articles for article (PubMed ID: 35089116)
1. Prospects for CAR T cell immunotherapy in autoimmune diseases: clues from Lupus.
Radic M; Neeli I; Marion T
Expert Opin Biol Ther; 2022 Apr; 22(4):499-507. PubMed ID: 35089116
[TBL] [Abstract][Full Text] [Related]
2. Application of CAR-T cell technology in autoimmune diseases and human immunodeficiency virus infection treatment.
Adabi N; Pordel S; Rezaee MA; Shobeiri FS; Shobeiri SS
J Gene Med; 2023 May; 25(5):e3484. PubMed ID: 36781390
[TBL] [Abstract][Full Text] [Related]
3. CAR T-cell therapy in autoimmune diseases.
Schett G; Mackensen A; Mougiakakos D
Lancet; 2023 Nov; 402(10416):2034-2044. PubMed ID: 37748491
[TBL] [Abstract][Full Text] [Related]
4. CAR T-Cell Therapy in Autoimmune Disease. Reply.
Müller F; Mackensen A; Schett G
N Engl J Med; 2024 May; 390(17):1631-1632. PubMed ID: 38692300
[No Abstract] [Full Text] [Related]
5. CAR T-Cell Therapy in Autoimmune Disease.
Howard JF; Vu T; Mozaffar T
N Engl J Med; 2024 May; 390(17):1629-1631. PubMed ID: 38692299
[No Abstract] [Full Text] [Related]
6. Chimeric antigen receptor T cell therapy: a new emerging landscape in autoimmune rheumatic diseases.
Lyu X; Gupta L; Tholouli E; Chinoy H
Rheumatology (Oxford); 2024 May; 63(5):1206-1216. PubMed ID: 37982747
[TBL] [Abstract][Full Text] [Related]
7. CAR T-Cell Therapy in Autoimmune Disease.
Merkt W; Lorenz HM; Schmitt M
N Engl J Med; 2024 May; 390(17):1628-1629. PubMed ID: 38692297
[No Abstract] [Full Text] [Related]
8. CAR T-Cell Therapy in Autoimmune Disease.
De Benedetti F; Diomedi Camassei F; Locatelli F
N Engl J Med; 2024 May; 390(17):1629. PubMed ID: 38692298
[No Abstract] [Full Text] [Related]
9. Chimeric Antigen Receptor Based Therapy as a Potential Approach in Autoimmune Diseases: How Close Are We to the Treatment?
Sadeqi Nezhad M; Seifalian A; Bagheri N; Yaghoubi S; Karimi MH; Adbollahpour-Alitappeh M
Front Immunol; 2020; 11():603237. PubMed ID: 33324420
[TBL] [Abstract][Full Text] [Related]
10. Immunobiology of chimeric antigen receptor T cells and novel designs.
Walsh Z; Yang Y; Kohler ME
Immunol Rev; 2019 Jul; 290(1):100-113. PubMed ID: 31355496
[TBL] [Abstract][Full Text] [Related]
11. Is There a Place for Chimeric Antigen Receptor-T Cells in the Treatment of Chronic Autoimmune Rheumatic Diseases?
Orvain C; Boulch M; Bousso P; Allanore Y; Avouac J
Arthritis Rheumatol; 2021 Nov; 73(11):1954-1965. PubMed ID: 34042325
[TBL] [Abstract][Full Text] [Related]
12. Dawn of CAR-T cell therapy in autoimmune diseases.
Liu Y; Dong M; Chu Y; Zhou L; You Y; Pang X; Yang S; Zhang L; Chen L; Zhu L; Xiao J; Wang W; Qin C; Tian D
Chin Med J (Engl); 2024 May; 137(10):1140-1150. PubMed ID: 38613216
[TBL] [Abstract][Full Text] [Related]
13. Strategies for enhancing adoptive T-cell immunotherapy against solid tumors using engineered cytokine signaling and other modalities.
Shum T; Kruse RL; Rooney CM
Expert Opin Biol Ther; 2018 Jun; 18(6):653-664. PubMed ID: 29727246
[TBL] [Abstract][Full Text] [Related]
14. Are chimeric antigen receptor T cells (CAR-T cells) the future in immunotherapy for autoimmune diseases?
Santamaria-Alza Y; Vasquez G
Inflamm Res; 2021 Jun; 70(6):651-663. PubMed ID: 34018005
[TBL] [Abstract][Full Text] [Related]
15. Imaging CAR-T Synapse as a Quality Control for CAR Engineering.
Xiao Q; Su X
Methods Mol Biol; 2023; 2654():503-512. PubMed ID: 37106204
[TBL] [Abstract][Full Text] [Related]
16. Paving New Roads for CARs.
Hyrenius-Wittsten A; Roybal KT
Trends Cancer; 2019 Oct; 5(10):583-592. PubMed ID: 31706506
[TBL] [Abstract][Full Text] [Related]
17. [CAR-T therapy for autoimmune diseases].
Alcaraz-Serna A; Porret R; Trueb L; Ribi C; Seebach J; Muller YD
Rev Med Suisse; 2024 Apr; 20(868):688-693. PubMed ID: 38568061
[TBL] [Abstract][Full Text] [Related]
18. CAR T cells for treating autoimmune diseases.
Blache U; Tretbar S; Koehl U; Mougiakakos D; Fricke S
RMD Open; 2023 Nov; 9(4):. PubMed ID: 37996128
[TBL] [Abstract][Full Text] [Related]
19. Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors.
Kosti P; Maher J; Arnold JN
Front Immunol; 2018; 9():1104. PubMed ID: 29872437
[TBL] [Abstract][Full Text] [Related]
20. Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance.
Boyiadzis MM; Dhodapkar MV; Brentjens RJ; Kochenderfer JN; Neelapu SS; Maus MV; Porter DL; Maloney DG; Grupp SA; Mackall CL; June CH; Bishop MR
J Immunother Cancer; 2018 Dec; 6(1):137. PubMed ID: 30514386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]